Participants 90 153 4
interferon alpha monotherapy relapsers with chronic hepatitis C
Participants 712 769 3
interferon monotherapy relapsers with chronic hepatitis C
Participants 779 858 4
Interferon alpha monotherapy relapsers with chronic hepatitis C were randomised
Participants 1181 1247 4
Only patients with negative HCV RNA at week 10 continued treatment
Participants 1308 1507 10
Thirty-seven patients were enrolled, 19 (6 females, median age 43) in the 24 week and 18 (5 females, median age 40) in the 48 week treatment arm. Baseline characteristics were similar in both groups.
Participants 1841 1949 3
Three patients discontinued treatment early (two due to moderate adverse events, one due to non-compliance).
